Laura Bukavina (@laurabukavinamd) 's Twitter Profile
Laura Bukavina

@laurabukavinamd

Uro Onc- Translational Research Lead GU ONC @CleClinicUro ๐Ÿ”ฌ bladder microbiome๐Ÿงซ๐Ÿงช ImmunoOnc @drexelmedicine @JohnsHopkinsSPH ๐Ÿ‡บ๐Ÿ‡ฆ@EUplatinum associate editor

ID: 2786427392

linkhttps://www.lerner.ccf.org/immunotherapy/bukavina/ calendar_today02-09-2014 18:09:32

5,5K Tweet

6,6K Takipรงi

1,1K Takip Edilen

Laura Bukavina (@laurabukavinamd) 's Twitter Profile Photo
Laura Bukavina
@laurabukavinamd

2 years ago

๐Ÿงต1/12 ๐Ÿ” Understanding #NMIBC: Key Categories ๐Ÿงฌ ๐Ÿšซ Refractory: High-grade disease persists at 6 months despite BCG therapy. Includes any stage/grade progression by 3 months. ๐Ÿ”„ Relapsing: High-grade recurrence after disease-free state at 6 months post-BCG. ๐Ÿ›‘ Intolerant:

๐Ÿงต1/12 ๐Ÿ” Understanding #NMIBC: Key Categories ๐Ÿงฌ ๐Ÿšซ Refractory: High-grade disease persists at 6 months despite BCG therapy. Includes any stage/grade progression by 3 months. ๐Ÿ”„ Relapsing: High-grade recurrence after disease-free state at 6 months post-BCG. ๐Ÿ›‘ Intolerant: